搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Danio rerio Homeobox protein OTX2 (otx2) CSB-YP835528DIL
CSB-EP835528DIL
CSB-BP835528DIL
CSB-MP835528DIL
CSB-EP835528DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine coronavirus Nucleoprotein (N) CSB-YP835529BJE
CSB-EP835529BJE
CSB-BP835529BJE
CSB-MP835529BJE
CSB-EP835529BJE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Hepatitis B virus genotype A1 subtype adw2 Protein X (X) CSB-YP835530HDL
CSB-EP835530HDL
CSB-BP835530HDL
CSB-MP835530HDL
CSB-EP835530HDL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Reston ebolavirus Envelope glycoprotein (GP), partial CSB-YP835531RCI
CSB-EP835531RCI
CSB-BP835531RCI
CSB-MP835531RCI
CSB-EP835531RCI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Equine arteritis virus Envelope small membrane protein (GP2a), partial CSB-YP835532EFH1
CSB-EP835532EFH1
CSB-BP835532EFH1
CSB-MP835532EFH1
CSB-EP835532EFH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Goose circovirus Probable capsid protein (Cap) CSB-YP835533GDAJ
CSB-EP835533GDAJ
CSB-BP835533GDAJ
CSB-MP835533GDAJ
CSB-EP835533GDAJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 460R (IIV6-460R) CSB-YP835534INA
CSB-EP835534INA
CSB-BP835534INA
CSB-MP835534INA
CSB-EP835534INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Probable deoxyuridine 5'-triphosphate nucleotidohydrolase (IIV6-438L) CSB-YP835535INA
CSB-EP835535INA
CSB-BP835535INA
CSB-MP835535INA
CSB-EP835535INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Putative hydrolase 414L (IIV6-414L) CSB-YP835536INA
CSB-EP835536INA
CSB-BP835536INA
CSB-MP835536INA
CSB-EP835536INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 385L (IIV6-385L) CSB-YP835537INA
CSB-EP835537INA
CSB-BP835537INA
CSB-MP835537INA
CSB-EP835537INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Probable RAD2-like endonuclease 369L (IIV6-369L) CSB-YP835538INA
CSB-EP835538INA
CSB-BP835538INA
CSB-MP835538INA
CSB-EP835538INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Putative transcription elongation factor S-II-like protein 349L (IIV6-349L) CSB-YP835539INA
CSB-EP835539INA
CSB-BP835539INA
CSB-MP835539INA
CSB-EP835539INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized RING finger protein 332L (IIV6-332L) CSB-YP835540INA
CSB-EP835540INA
CSB-BP835540INA
CSB-MP835540INA
CSB-EP835540INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Putative KilA-N domain-containing protein 313L (IIV6-313L) CSB-YP835541INA
CSB-EP835541INA
CSB-BP835541INA
CSB-MP835541INA
CSB-EP835541INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Transmembrane protein 300R (IIV6-300R), partial CSB-YP835542INA1
CSB-EP835542INA1
CSB-BP835542INA1
CSB-MP835542INA1
CSB-EP835542INA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 273R (IIV6-273R) CSB-YP835543INA
CSB-EP835543INA
CSB-BP835543INA
CSB-MP835543INA
CSB-EP835543INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 250L (IIV6-250L) CSB-YP835544INA
CSB-EP835544INA
CSB-BP835544INA
CSB-MP835544INA
CSB-EP835544INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 240R (IIV6-240R) CSB-YP835545INA
CSB-EP835545INA
CSB-BP835545INA
CSB-MP835545INA
CSB-EP835545INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Uncharacterized protein 227L (IIV6-227L), partial CSB-YP835546INA
CSB-EP835546INA
CSB-BP835546INA
CSB-MP835546INA
CSB-EP835546INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Invertebrate iridescent virus 6 Putative MSV199 domain-containing protein 212L (IIV6-212L) CSB-YP835547INA
CSB-EP835547INA
CSB-BP835547INA
CSB-MP835547INA
CSB-EP835547INA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>